Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Anticipated Shortage

NEURONTIN

BGP PHARMA ULC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of NEURONTIN in Canada?

A shortage of NEURONTIN 300MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated November 9, 2026), but it has not started yet.

Why is NEURONTIN not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will NEURONTIN be available again?

The manufacturer's estimated resolution date is January 19, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found
StatusAnticipated Shortage
Same-ingredient products on file6 products
Expected resolution~2 months remaining (estimate)
Affected strength300MG
Report last updated2026-11-09
Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

GABAPENTIN

SIVEM PHARMACEUTICALS ULC

300MG · DIN 02246315

Same strengthSame dosage formSame routeNo current shortage

AURO-GABAPENTIN

AURO PHARMA INC

300MG · DIN 02321211

Same strengthSame dosage formSame routeNo current shortage

Other Products

NEURONTIN

BGP PHARMA ULC

100MG · DIN 02084260

Different strengthSame dosage formSame routeNo current shortage

PMS-GABAPENTIN

PHARMASCIENCE INC

400MG · DIN 02243448

Different strengthSame dosage formSame routeNo current shortage

TEVA-GABAPENTIN

TEVA CANADA LIMITED

100MG · DIN 02244513

Different strengthSame dosage formSame routeNo current shortage

RIVA-GABAPENTIN

LABORATOIRE RIVA INC.

100MG · DIN 02251167

Different strengthSame dosage formSame routeNo current shortage

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02084279

Strength

300MG

Dosage Form

CAPSULE

Route

ORAL

Active Ingredient

GABAPENTIN

See all GABAPENTIN products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History